Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to assess whether an adaptation of cyclosporine (CsA) dose
according to a longitudinal calcineurin (CN) activity monitoring would prevent the onset of
graft-versus-host disease (GVHD).